Skip to content

Clinical trials

Phase 2 Stroke trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 2 Country / region: Germany Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20031
20042
20053
20062
20071
20081
20092
20102
20113
20124
20132
20162
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated6
Unknown status6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital Heidelberg5
Astellas Pharma Inc2
GlaxoSmithKline2
PAION Deutschland GmbH2
ThromboGenics2
AdvanceCor GmbH1
Axaron Bioscience AG1
Bayer1
Biogen1
Charite University, Berlin, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke30
Ischemic Stroke16
Hypothermia5
Cerebrovascular Disorders4
Hemorrhagic Stroke4
Intracranial Hemorrhages3
Ischemic Attack, Transient3
Atrial Fibrillation2
Cerebral Infarction2
Amaurosis Fugax1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.